

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | response to peptidoglycan (GO:0032494) | 5.74131002 |
| 2 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.45530482 |
| 3 | negative regulation of interleukin-12 production (GO:0032695) | 5.12271171 |
| 4 | macrophage activation involved in immune response (GO:0002281) | 5.05946549 |
| 5 | neuron cell-cell adhesion (GO:0007158) | 4.99523735 |
| 6 | neutrophil activation involved in immune response (GO:0002283) | 4.98135309 |
| 7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.93509277 |
| 8 | central nervous system myelination (GO:0022010) | 4.82511843 |
| 9 | axon ensheathment in central nervous system (GO:0032291) | 4.82511843 |
| 10 | modulation by symbiont of host defense response (GO:0052031) | 4.73083259 |
| 11 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.73083259 |
| 12 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.73083259 |
| 13 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.73083259 |
| 14 | modulation by symbiont of host immune response (GO:0052553) | 4.73083259 |
| 15 | positive regulation by symbiont of host defense response (GO:0052509) | 4.73083259 |
| 16 | long-chain fatty acid biosynthetic process (GO:0042759) | 4.67297661 |
| 17 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.58319296 |
| 18 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.52292074 |
| 19 | ATP synthesis coupled proton transport (GO:0015986) | 4.52292074 |
| 20 | immunoglobulin mediated immune response (GO:0016064) | 4.38570849 |
| 21 | protein neddylation (GO:0045116) | 4.33067481 |
| 22 | transmission of nerve impulse (GO:0019226) | 4.16028878 |
| 23 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 4.14979906 |
| 24 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.10881383 |
| 25 | respiratory electron transport chain (GO:0022904) | 4.07480518 |
| 26 | chaperone-mediated protein transport (GO:0072321) | 4.03713099 |
| 27 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.96165453 |
| 28 | neuronal action potential propagation (GO:0019227) | 3.96042964 |
| 29 | electron transport chain (GO:0022900) | 3.95543391 |
| 30 | regulation of mast cell degranulation (GO:0043304) | 3.94600568 |
| 31 | presynaptic membrane assembly (GO:0097105) | 3.94559973 |
| 32 | regulation of leukocyte degranulation (GO:0043300) | 3.91745545 |
| 33 | dopamine transport (GO:0015872) | 3.91272074 |
| 34 | cellular extravasation (GO:0045123) | 3.87432283 |
| 35 | neurotransmitter uptake (GO:0001504) | 3.86779872 |
| 36 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.86043461 |
| 37 | response to muramyl dipeptide (GO:0032495) | 3.83794835 |
| 38 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.83460892 |
| 39 | negative regulation of cell killing (GO:0031342) | 3.83460892 |
| 40 | myeloid cell activation involved in immune response (GO:0002275) | 3.79204425 |
| 41 | startle response (GO:0001964) | 3.78645211 |
| 42 | vocalization behavior (GO:0071625) | 3.75568326 |
| 43 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.73514978 |
| 44 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.70958862 |
| 45 | presynaptic membrane organization (GO:0097090) | 3.70160248 |
| 46 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.68293215 |
| 47 | detection of molecule of bacterial origin (GO:0032490) | 3.65347247 |
| 48 | macrophage activation (GO:0042116) | 3.65081852 |
| 49 | detection of other organism (GO:0098543) | 3.64383441 |
| 50 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.61246005 |
| 51 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.60514732 |
| 52 | positive regulation of mast cell degranulation (GO:0043306) | 3.59099792 |
| 53 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.59099792 |
| 54 | synaptic vesicle exocytosis (GO:0016079) | 3.59065550 |
| 55 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.54284349 |
| 56 | microglial cell activation (GO:0001774) | 3.53466446 |
| 57 | germinal center formation (GO:0002467) | 3.52366772 |
| 58 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.50730824 |
| 59 | protein localization to synapse (GO:0035418) | 3.50571149 |
| 60 | granulocyte activation (GO:0036230) | 3.48165681 |
| 61 | positive regulation of mast cell activation (GO:0033005) | 3.44991215 |
| 62 | regulation of gamma-delta T cell activation (GO:0046643) | 3.44459629 |
| 63 | L-amino acid import (GO:0043092) | 3.43477832 |
| 64 | detection of bacterium (GO:0016045) | 3.42864299 |
| 65 | neuron recognition (GO:0008038) | 3.42112445 |
| 66 | glycosphingolipid catabolic process (GO:0046479) | 3.38814824 |
| 67 | detection of external biotic stimulus (GO:0098581) | 3.38798925 |
| 68 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.38169418 |
| 69 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.36632605 |
| 70 | regulation of regulated secretory pathway (GO:1903305) | 3.34401962 |
| 71 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.30003688 |
| 72 | neutrophil activation (GO:0042119) | 3.29229948 |
| 73 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.29039190 |
| 74 | glycerophospholipid catabolic process (GO:0046475) | 3.28025045 |
| 75 | glutamate receptor signaling pathway (GO:0007215) | 3.26681980 |
| 76 | respiratory burst (GO:0045730) | 3.23658611 |
| 77 | T-helper 1 type immune response (GO:0042088) | 3.23526750 |
| 78 | mannose metabolic process (GO:0006013) | 3.23464713 |
| 79 | regulation of mast cell activation (GO:0033003) | 3.23154169 |
| 80 | amino sugar catabolic process (GO:0046348) | 3.23139535 |
| 81 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.22841408 |
| 82 | positive regulation of leukocyte degranulation (GO:0043302) | 3.22553944 |
| 83 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.20499349 |
| 84 | response to host immune response (GO:0052572) | 3.20499349 |
| 85 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.19320954 |
| 86 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.19277909 |
| 87 | B cell mediated immunity (GO:0019724) | 3.19138509 |
| 88 | positive regulation of protein homodimerization activity (GO:0090073) | 3.18957188 |
| 89 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.18083261 |
| 90 | positive regulation of B cell differentiation (GO:0045579) | 3.17001593 |
| 91 | positive regulation of synapse assembly (GO:0051965) | 3.15151136 |
| 92 | neuron-neuron synaptic transmission (GO:0007270) | 3.14391273 |
| 93 | regulation of protein kinase A signaling (GO:0010738) | 3.13489780 |
| 94 | adenosine receptor signaling pathway (GO:0001973) | 3.13094403 |
| 95 | negative regulation of granulocyte differentiation (GO:0030853) | 3.11114944 |
| 96 | positive regulation of antigen processing and presentation (GO:0002579) | 3.09583682 |
| 97 | regulation of hypersensitivity (GO:0002883) | 3.08403551 |
| 98 | negative regulation of neurotransmitter transport (GO:0051589) | 3.07807834 |
| 99 | synaptic transmission, glutamatergic (GO:0035249) | 3.07430710 |
| 100 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.06953260 |
| 101 | response to protozoan (GO:0001562) | 3.06013170 |
| 102 | fatty acid elongation (GO:0030497) | 3.05220918 |
| 103 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.04411698 |
| 104 | detection of biotic stimulus (GO:0009595) | 3.04191983 |
| 105 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.03146706 |
| 106 | protein complex biogenesis (GO:0070271) | 3.02806679 |
| 107 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.01620515 |
| 108 | gamma-aminobutyric acid transport (GO:0015812) | 3.01287154 |
| 109 | glycolipid catabolic process (GO:0019377) | 3.00624473 |
| 110 | macrophage differentiation (GO:0030225) | 2.99673758 |
| 111 | regulation of catecholamine metabolic process (GO:0042069) | 2.99308533 |
| 112 | regulation of dopamine metabolic process (GO:0042053) | 2.99308533 |
| 113 | N-acetylneuraminate metabolic process (GO:0006054) | 2.98956783 |
| 114 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.97662918 |
| 115 | NIK/NF-kappaB signaling (GO:0038061) | 2.97429416 |
| 116 | defense response to protozoan (GO:0042832) | 2.97252464 |
| 117 | regulation of vesicle fusion (GO:0031338) | 2.96897999 |
| 118 | adult walking behavior (GO:0007628) | 2.96559080 |
| 119 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.95918184 |
| 120 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.95918184 |
| 121 | NADH dehydrogenase complex assembly (GO:0010257) | 2.95918184 |
| 122 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.95395155 |
| 123 | righting reflex (GO:0060013) | 2.94337688 |
| 124 | phagosome maturation (GO:0090382) | 2.92567172 |
| 125 | regulation of antigen processing and presentation (GO:0002577) | 2.90329934 |
| 126 | leukocyte aggregation (GO:0070486) | 2.90256318 |
| 127 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.89971324 |
| 128 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.88981196 |
| 129 | neuron remodeling (GO:0016322) | 2.87526723 |
| 130 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.86919964 |
| 131 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.86919964 |
| 132 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.86341172 |
| 133 | response to host (GO:0075136) | 2.86341172 |
| 134 | response to host defenses (GO:0052200) | 2.86341172 |
| 135 | myeloid dendritic cell activation (GO:0001773) | 2.86034274 |
| 136 | hydrogen ion transmembrane transport (GO:1902600) | 2.84475775 |
| 137 | oligosaccharide catabolic process (GO:0009313) | 2.84390326 |
| 138 | dendritic spine morphogenesis (GO:0060997) | 2.83503883 |
| 139 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.83491026 |
| 140 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.83355966 |
| 141 | regulation of mononuclear cell migration (GO:0071675) | 2.83318685 |
| 142 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.83166573 |
| 143 | myeloid dendritic cell differentiation (GO:0043011) | 2.82212741 |
| 144 | protein localization to cilium (GO:0061512) | 2.81155428 |
| 145 | myeloid leukocyte activation (GO:0002274) | 2.80929888 |
| 146 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.80917304 |
| 147 | neurotransmitter transport (GO:0006836) | 2.80300996 |
| 148 | postsynaptic membrane organization (GO:0001941) | 2.80114128 |
| 149 | substantia nigra development (GO:0021762) | 2.80046036 |
| 150 | transferrin transport (GO:0033572) | 2.79378581 |
| 151 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.79078533 |
| 152 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.79035947 |
| 153 | regulation of macrophage chemotaxis (GO:0010758) | 2.77586341 |
| 154 | catecholamine transport (GO:0051937) | 2.76237975 |
| 155 | amino acid import (GO:0043090) | 2.76063595 |
| 156 | regulation of interferon-alpha production (GO:0032647) | 2.76038365 |
| 157 | GTP biosynthetic process (GO:0006183) | 2.75797075 |
| 158 | regulation of glutamate secretion (GO:0014048) | 2.75701418 |
| 159 | regulation of postsynaptic membrane potential (GO:0060078) | 2.75152008 |
| 160 | negative regulation of protein localization to cell surface (GO:2000009) | 2.75068293 |
| 161 | regulation of synaptic vesicle transport (GO:1902803) | 2.74188377 |
| 162 | positive regulation of regulated secretory pathway (GO:1903307) | 2.73902011 |
| 163 | neutrophil chemotaxis (GO:0030593) | 2.72723224 |
| 164 | leukocyte degranulation (GO:0043299) | 2.72398031 |
| 165 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.72002552 |
| 166 | positive regulation of membrane potential (GO:0045838) | 2.71939274 |
| 167 | neuromuscular process controlling posture (GO:0050884) | 2.71518339 |
| 168 | regulation of superoxide anion generation (GO:0032928) | 2.70746044 |
| 169 | response to thyroid hormone (GO:0097066) | 2.70640513 |
| 170 | cellular response to ethanol (GO:0071361) | 2.69709216 |
| 171 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.69705971 |
| 172 | long-term memory (GO:0007616) | 2.69309032 |
| 173 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.68972392 |
| 174 | T cell migration (GO:0072678) | 2.67574355 |
| 175 | response to histamine (GO:0034776) | 2.67426946 |
| 176 | mature B cell differentiation involved in immune response (GO:0002313) | 2.66520514 |
| 177 | behavioral response to cocaine (GO:0048148) | 2.65763607 |
| 178 | positive regulation of interferon-alpha production (GO:0032727) | 2.65174883 |
| 179 | neutrophil migration (GO:1990266) | 2.65017360 |
| 180 | neurotransmitter catabolic process (GO:0042135) | 2.65013958 |
| 181 | opioid receptor signaling pathway (GO:0038003) | 2.63907787 |
| 182 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.63745242 |
| 183 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.62241326 |
| 184 | proton transport (GO:0015992) | 2.60075604 |
| 185 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 2.59782192 |
| 186 | regulation of neurotransmitter levels (GO:0001505) | 2.59278690 |
| 187 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.58974175 |
| 188 | membrane hyperpolarization (GO:0060081) | 2.57849919 |
| 189 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.56676338 |
| 190 | trivalent inorganic cation transport (GO:0072512) | 2.56479323 |
| 191 | ferric iron transport (GO:0015682) | 2.56479323 |
| 192 | synapse assembly (GO:0007416) | 2.56211134 |
| 193 | neurotransmitter secretion (GO:0007269) | 2.54929113 |
| 194 | learning (GO:0007612) | 2.54314625 |
| 195 | neuronal ion channel clustering (GO:0045161) | 2.54218476 |
| 196 | axonal fasciculation (GO:0007413) | 2.53952019 |
| 197 | hydrogen transport (GO:0006818) | 2.53584310 |
| 198 | locomotory exploration behavior (GO:0035641) | 2.52410705 |
| 199 | mating behavior (GO:0007617) | 2.50333540 |
| 200 | regulation of respiratory gaseous exchange (GO:0043576) | 2.49096505 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.41523318 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.53658938 |
| 3 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.76206024 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.75207175 |
| 5 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.65922241 |
| 6 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.53707140 |
| 7 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.30529850 |
| 8 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.27126935 |
| 9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.16924809 |
| 10 | * VDR_24763502_ChIP-Seq_THP-1_Human | 3.10746865 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.06476642 |
| 12 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.83184750 |
| 13 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.82705207 |
| 14 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.77931325 |
| 15 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.76922247 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.64999490 |
| 17 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.63750402 |
| 18 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.56254033 |
| 19 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.54828646 |
| 20 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.50366887 |
| 21 | MYC_22102868_ChIP-Seq_BL_Human | 2.47044503 |
| 22 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.46848926 |
| 23 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.46035985 |
| 24 | SPI1_23127762_ChIP-Seq_K562_Human | 2.41492822 |
| 25 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.39770984 |
| 26 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.32555263 |
| 27 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.29779566 |
| 28 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.29494640 |
| 29 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.29068908 |
| 30 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.28093942 |
| 31 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.27891572 |
| 32 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.26500121 |
| 33 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.24411788 |
| 34 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.21857373 |
| 35 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.20503710 |
| 36 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.18438760 |
| 37 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.18058454 |
| 38 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.17885560 |
| 39 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.16549410 |
| 40 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.14201235 |
| 41 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.11721219 |
| 42 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.07698853 |
| 43 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.05200204 |
| 44 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.05106862 |
| 45 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.03443573 |
| 46 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.03443573 |
| 47 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.02393567 |
| 48 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.01646694 |
| 49 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.01328196 |
| 50 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.01029595 |
| 51 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.98972754 |
| 52 | VDR_22108803_ChIP-Seq_LS180_Human | 1.98067237 |
| 53 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.96497764 |
| 54 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.95971206 |
| 55 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.94713468 |
| 56 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.94187151 |
| 57 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.92390067 |
| 58 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.91676971 |
| 59 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.91548603 |
| 60 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.91267111 |
| 61 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.89468564 |
| 62 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.87863861 |
| 63 | MAF_26560356_Chip-Seq_TH1_Human | 1.86916821 |
| 64 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.85749159 |
| 65 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.85406198 |
| 66 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.84502550 |
| 67 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.84235987 |
| 68 | FUS_26573619_Chip-Seq_HEK293_Human | 1.81428234 |
| 69 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.78688227 |
| 70 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77586324 |
| 71 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.75321278 |
| 72 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.72419973 |
| 73 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.70889414 |
| 74 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.70085358 |
| 75 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.69694655 |
| 76 | P300_19829295_ChIP-Seq_ESCs_Human | 1.67652834 |
| 77 | UTX_26944678_Chip-Seq_JUKART_Human | 1.66297816 |
| 78 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.62728724 |
| 79 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.60205387 |
| 80 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.59458727 |
| 81 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.58433693 |
| 82 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.58141884 |
| 83 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.57603191 |
| 84 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.56536275 |
| 85 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.55951408 |
| 86 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.55725032 |
| 87 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.55129763 |
| 88 | MAF_26560356_Chip-Seq_TH2_Human | 1.51471555 |
| 89 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.48674122 |
| 90 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.47995127 |
| 91 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.47890143 |
| 92 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.47595550 |
| 93 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.47098640 |
| 94 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.46759241 |
| 95 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.46097866 |
| 96 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.44437277 |
| 97 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.43712700 |
| 98 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.43695565 |
| 99 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.43000190 |
| 100 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.42538976 |
| 101 | MYB_26560356_Chip-Seq_TH2_Human | 1.40743333 |
| 102 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.40458840 |
| 103 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40187459 |
| 104 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.40161177 |
| 105 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.39454946 |
| 106 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.37043640 |
| 107 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.36646397 |
| 108 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.36315648 |
| 109 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.35446857 |
| 110 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.34310216 |
| 111 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.34293519 |
| 112 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.32868245 |
| 113 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32650542 |
| 114 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.32250610 |
| 115 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.31283287 |
| 116 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.30699602 |
| 117 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29543184 |
| 118 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.29429142 |
| 119 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.27680211 |
| 120 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.27011561 |
| 121 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.25477514 |
| 122 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.24996353 |
| 123 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.24795691 |
| 124 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.24661832 |
| 125 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.24498403 |
| 126 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.24405846 |
| 127 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.24261771 |
| 128 | * MYB_26560356_Chip-Seq_TH1_Human | 1.23230392 |
| 129 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.22261836 |
| 130 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.21623231 |
| 131 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.20872418 |
| 132 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.20805015 |
| 133 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.20450183 |
| 134 | GATA1_19941826_ChIP-Seq_K562_Human | 1.20444683 |
| 135 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.20196248 |
| 136 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.19875932 |
| 137 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.19744761 |
| 138 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.19530935 |
| 139 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.18985433 |
| 140 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.18553346 |
| 141 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18531292 |
| 142 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.18303859 |
| 143 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.17894145 |
| 144 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17866095 |
| 145 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.17478795 |
| 146 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16767763 |
| 147 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.15645136 |
| 148 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.15143166 |
| 149 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.14814791 |
| 150 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.14361934 |
| 151 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.14201790 |
| 152 | JUN_21703547_ChIP-Seq_K562_Human | 1.12805356 |
| 153 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.12527433 |
| 154 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.12332285 |
| 155 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.12170187 |
| 156 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.11761255 |
| 157 | GATA1_22025678_ChIP-Seq_K562_Human | 1.10804025 |
| 158 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.10575326 |
| 159 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.10341520 |
| 160 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09358854 |
| 161 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.09132667 |
| 162 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.08959650 |
| 163 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.08484167 |
| 164 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.08191717 |
| 165 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.08137142 |
| 166 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.07652947 |
| 167 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07353042 |
| 168 | P68_20966046_ChIP-Seq_HELA_Human | 1.05413306 |
| 169 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.05266201 |
| 170 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04977672 |
| 171 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.03823598 |
| 172 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.02599275 |
| 173 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.02469984 |
| 174 | AR_25329375_ChIP-Seq_VCAP_Human | 1.02247644 |
| 175 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.02158319 |
| 176 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.02031379 |
| 177 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.00340460 |
| 178 | TCF4_23295773_ChIP-Seq_U87_Human | 1.00250849 |
| 179 | EWS_26573619_Chip-Seq_HEK293_Human | 0.99981572 |
| 180 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.98206919 |
| 181 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.97726582 |
| 182 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.97600395 |
| 183 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.97400195 |
| 184 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.96773136 |
| 185 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96524457 |
| 186 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.96500625 |
| 187 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.96359953 |
| 188 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.96318382 |
| 189 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.96278259 |
| 190 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.96173402 |
| 191 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.96043266 |
| 192 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.95996206 |
| 193 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.95745529 |
| 194 | KDM2B_26808549_Chip-Seq_REH_Human | 0.95468107 |
| 195 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95259038 |
| 196 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95211476 |
| 197 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.95089647 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 5.02201804 |
| 2 | MP0003303_peritoneal_inflammation | 4.17403044 |
| 3 | MP0005058_abnormal_lysosome_morphology | 4.04387166 |
| 4 | MP0003436_decreased_susceptibility_to | 3.63961272 |
| 5 | MP0001529_abnormal_vocalization | 3.50075081 |
| 6 | MP0004859_abnormal_synaptic_plasticity | 3.42813170 |
| 7 | MP0003172_abnormal_lysosome_physiology | 3.22002814 |
| 8 | MP0001835_abnormal_antigen_presentation | 3.21984689 |
| 9 | MP0009745_abnormal_behavioral_response | 3.18514116 |
| 10 | MP0003635_abnormal_synaptic_transmissio | 3.13848304 |
| 11 | MP0006082_CNS_inflammation | 3.10349180 |
| 12 | MP0002064_seizures | 3.09627730 |
| 13 | * MP0002419_abnormal_innate_immunity | 3.01543523 |
| 14 | MP0009046_muscle_twitch | 3.01283904 |
| 15 | MP0004270_analgesia | 2.92527414 |
| 16 | MP0002272_abnormal_nervous_system | 2.84207578 |
| 17 | MP0009278_abnormal_bone_marrow | 2.81424430 |
| 18 | MP0002148_abnormal_hypersensitivity_rea | 2.77712011 |
| 19 | MP0003724_increased_susceptibility_to | 2.75946035 |
| 20 | MP0009785_altered_susceptibility_to | 2.75566228 |
| 21 | MP0006276_abnormal_autonomic_nervous | 2.68365609 |
| 22 | MP0001968_abnormal_touch/_nociception | 2.65803678 |
| 23 | MP0001486_abnormal_startle_reflex | 2.65016992 |
| 24 | MP0005025_abnormal_response_to | 2.63692997 |
| 25 | MP0005671_abnormal_response_to | 2.63405474 |
| 26 | MP0005423_abnormal_somatic_nervous | 2.61070535 |
| 27 | MP0002572_abnormal_emotion/affect_behav | 2.58834441 |
| 28 | MP0005000_abnormal_immune_tolerance | 2.56494405 |
| 29 | MP0005387_immune_system_phenotype | 2.50737790 |
| 30 | MP0001790_abnormal_immune_system | 2.50737790 |
| 31 | MP0001905_abnormal_dopamine_level | 2.50091118 |
| 32 | MP0005409_darkened_coat_color | 2.49139006 |
| 33 | MP0003300_gastrointestinal_ulcer | 2.47565773 |
| 34 | MP0009840_abnormal_foam_cell | 2.47393816 |
| 35 | MP0002063_abnormal_learning/memory/cond | 2.45075466 |
| 36 | MP0000685_abnormal_immune_system | 2.43887722 |
| 37 | MP0001440_abnormal_grooming_behavior | 2.41708848 |
| 38 | MP0004142_abnormal_muscle_tone | 2.37352710 |
| 39 | MP0002734_abnormal_mechanical_nocicepti | 2.37044529 |
| 40 | MP0002736_abnormal_nociception_after | 2.33086799 |
| 41 | MP0001501_abnormal_sleep_pattern | 2.26909574 |
| 42 | MP0003075_altered_response_to | 2.24999211 |
| 43 | * MP0002452_abnormal_antigen_presenting | 2.22550468 |
| 44 | MP0001800_abnormal_humoral_immune | 2.20502062 |
| 45 | * MP0002723_abnormal_immune_serum | 2.17516620 |
| 46 | MP0005451_abnormal_body_composition | 2.15231362 |
| 47 | MP0001970_abnormal_pain_threshold | 2.04213847 |
| 48 | MP0004510_myositis | 2.03431004 |
| 49 | MP0005464_abnormal_platelet_physiology | 2.02426103 |
| 50 | * MP0002420_abnormal_adaptive_immunity | 2.02194405 |
| 51 | MP0005645_abnormal_hypothalamus_physiol | 2.02131568 |
| 52 | * MP0001819_abnormal_immune_cell | 2.01427572 |
| 53 | MP0000920_abnormal_myelination | 1.97594889 |
| 54 | MP0003191_abnormal_cellular_cholesterol | 1.97382202 |
| 55 | MP0001545_abnormal_hematopoietic_system | 1.97235787 |
| 56 | MP0005397_hematopoietic_system_phenotyp | 1.97235787 |
| 57 | MP0001533_abnormal_skeleton_physiology | 1.94602682 |
| 58 | MP0002735_abnormal_chemical_nociception | 1.90740692 |
| 59 | MP0002067_abnormal_sensory_capabilities | 1.88986729 |
| 60 | MP0002733_abnormal_thermal_nociception | 1.85161535 |
| 61 | MP0004742_abnormal_vestibular_system | 1.81751636 |
| 62 | MP0005171_absent_coat_pigmentation | 1.81488313 |
| 63 | MP0004947_skin_inflammation | 1.77832716 |
| 64 | MP0000343_altered_response_to | 1.76167195 |
| 65 | MP0001188_hyperpigmentation | 1.74121661 |
| 66 | MP0000778_abnormal_nervous_system | 1.72187116 |
| 67 | MP0002998_abnormal_bone_remodeling | 1.70193485 |
| 68 | MP0004924_abnormal_behavior | 1.68526860 |
| 69 | MP0005386_behavior/neurological_phenoty | 1.68526860 |
| 70 | MP0001853_heart_inflammation | 1.64426539 |
| 71 | MP0008057_abnormal_DNA_replication | 1.61690377 |
| 72 | * MP0001845_abnormal_inflammatory_respons | 1.61548646 |
| 73 | MP0002184_abnormal_innervation | 1.60711180 |
| 74 | MP0002405_respiratory_system_inflammati | 1.59872570 |
| 75 | MP0005310_abnormal_salivary_gland | 1.59868878 |
| 76 | MP0003136_yellow_coat_color | 1.58736102 |
| 77 | MP0009764_decreased_sensitivity_to | 1.54738960 |
| 78 | MP0002557_abnormal_social/conspecific_i | 1.53509968 |
| 79 | MP0010155_abnormal_intestine_physiology | 1.51973365 |
| 80 | MP0003122_maternal_imprinting | 1.51731569 |
| 81 | MP0000716_abnormal_immune_system | 1.49151591 |
| 82 | * MP0008469_abnormal_protein_level | 1.46269242 |
| 83 | MP0002822_catalepsy | 1.45534226 |
| 84 | MP0003329_amyloid_beta_deposits | 1.41887117 |
| 85 | MP0005167_abnormal_blood-brain_barrier | 1.39385349 |
| 86 | MP0002398_abnormal_bone_marrow | 1.37441669 |
| 87 | MP0000858_altered_metastatic_potential | 1.37206194 |
| 88 | MP0003828_pulmonary_edema | 1.33093337 |
| 89 | MP0001984_abnormal_olfaction | 1.32024957 |
| 90 | MP0005166_decreased_susceptibility_to | 1.31012048 |
| 91 | MP0003690_abnormal_glial_cell | 1.30049331 |
| 92 | MP0009333_abnormal_splenocyte_physiolog | 1.29997324 |
| 93 | MP0002066_abnormal_motor_capabilities/c | 1.28561500 |
| 94 | MP0003806_abnormal_nucleotide_metabolis | 1.28351902 |
| 95 | MP0002837_dystrophic_cardiac_calcinosis | 1.26787350 |
| 96 | MP0002882_abnormal_neuron_morphology | 1.25318040 |
| 97 | MP0000015_abnormal_ear_pigmentation | 1.25282097 |
| 98 | MP0005551_abnormal_eye_electrophysiolog | 1.24146407 |
| 99 | MP0009379_abnormal_foot_pigmentation | 1.24107484 |
| 100 | MP0008569_lethality_at_weaning | 1.23840140 |
| 101 | MP0000689_abnormal_spleen_morphology | 1.21674643 |
| 102 | MP0003448_altered_tumor_morphology | 1.19878545 |
| 103 | MP0000955_abnormal_spinal_cord | 1.19443540 |
| 104 | MP0001485_abnormal_pinna_reflex | 1.19363026 |
| 105 | MP0001986_abnormal_taste_sensitivity | 1.18114039 |
| 106 | MP0010386_abnormal_urinary_bladder | 1.17897580 |
| 107 | MP0002429_abnormal_blood_cell | 1.17533541 |
| 108 | MP0001963_abnormal_hearing_physiology | 1.16636196 |
| 109 | MP0008004_abnormal_stomach_pH | 1.15805444 |
| 110 | MP0003183_abnormal_peptide_metabolism | 1.15200029 |
| 111 | MP0004381_abnormal_hair_follicle | 1.14953100 |
| 112 | MP0002229_neurodegeneration | 1.14582964 |
| 113 | MP0003763_abnormal_thymus_physiology | 1.14170890 |
| 114 | MP0003879_abnormal_hair_cell | 1.13278241 |
| 115 | MP0002396_abnormal_hematopoietic_system | 1.11769563 |
| 116 | MP0002722_abnormal_immune_system | 1.11308982 |
| 117 | MP0003656_abnormal_erythrocyte_physiolo | 1.10352329 |
| 118 | MP0002102_abnormal_ear_morphology | 1.10331791 |
| 119 | MP0003453_abnormal_keratinocyte_physiol | 1.08322741 |
| 120 | MP0005646_abnormal_pituitary_gland | 1.07491364 |
| 121 | MP0002876_abnormal_thyroid_physiology | 1.07329317 |
| 122 | MP0006072_abnormal_retinal_apoptosis | 1.04411640 |
| 123 | MP0002638_abnormal_pupillary_reflex | 1.04401366 |
| 124 | MP0003634_abnormal_glial_cell | 1.02178110 |
| 125 | MP0001502_abnormal_circadian_rhythm | 1.00168927 |
| 126 | MP0002752_abnormal_somatic_nervous | 0.99706053 |
| 127 | MP0008872_abnormal_physiological_respon | 0.99314025 |
| 128 | MP0006292_abnormal_olfactory_placode | 0.98838690 |
| 129 | MP0002277_abnormal_respiratory_mucosa | 0.97410028 |
| 130 | MP0005076_abnormal_cell_differentiation | 0.93834927 |
| 131 | MP0002139_abnormal_hepatobiliary_system | 0.93560635 |
| 132 | MP0005379_endocrine/exocrine_gland_phen | 0.92818905 |
| 133 | MP0004808_abnormal_hematopoietic_stem | 0.92114569 |
| 134 | MP0004883_abnormal_blood_vessel | 0.90173597 |
| 135 | MP0000026_abnormal_inner_ear | 0.89636772 |
| 136 | MP0003631_nervous_system_phenotype | 0.88655965 |
| 137 | MP0002152_abnormal_brain_morphology | 0.88452093 |
| 138 | MP0001851_eye_inflammation | 0.87985605 |
| 139 | MP0008877_abnormal_DNA_methylation | 0.87333219 |
| 140 | MP0004811_abnormal_neuron_physiology | 0.87153902 |
| 141 | MP0003632_abnormal_nervous_system | 0.86120738 |
| 142 | MP0005164_abnormal_response_to | 0.84665387 |
| 143 | MP0003787_abnormal_imprinting | 0.83586043 |
| 144 | MP0003866_abnormal_defecation | 0.81725455 |
| 145 | MP0008260_abnormal_autophagy | 0.81631965 |
| 146 | MP0005535_abnormal_body_temperature | 0.79785698 |
| 147 | MP0003633_abnormal_nervous_system | 0.79577355 |
| 148 | MP0003091_abnormal_cell_migration | 0.79478148 |
| 149 | MP0005410_abnormal_fertilization | 0.78990823 |
| 150 | MP0003938_abnormal_ear_development | 0.78469901 |
| 151 | MP0000631_abnormal_neuroendocrine_gland | 0.77777964 |
| 152 | MP0009763_increased_sensitivity_to | 0.77655355 |
| 153 | MP0000465_gastrointestinal_hemorrhage | 0.76792247 |
| 154 | MP0002163_abnormal_gland_morphology | 0.76374610 |
| 155 | MP0001727_abnormal_embryo_implantation | 0.75206448 |
| 156 | MP0000604_amyloidosis | 0.74009384 |
| 157 | MP0001663_abnormal_digestive_system | 0.73967736 |
| 158 | MP0006035_abnormal_mitochondrial_morpho | 0.72757589 |
| 159 | MP0008874_decreased_physiological_sensi | 0.72721034 |
| 160 | MP0005174_abnormal_tail_pigmentation | 0.72561254 |
| 161 | MP0004885_abnormal_endolymph | 0.72268925 |
| 162 | MP0000703_abnormal_thymus_morphology | 0.72196580 |
| 163 | MP0001873_stomach_inflammation | 0.71556884 |
| 164 | MP0000490_abnormal_crypts_of | 0.70908644 |
| 165 | MP0003795_abnormal_bone_structure | 0.70354248 |
| 166 | MP0002751_abnormal_autonomic_nervous | 0.68941516 |
| 167 | MP0003718_maternal_effect | 0.68154837 |
| 168 | MP0005394_taste/olfaction_phenotype | 0.67721709 |
| 169 | MP0005499_abnormal_olfactory_system | 0.67721709 |
| 170 | MP0005253_abnormal_eye_physiology | 0.67571624 |
| 171 | MP0004185_abnormal_adipocyte_glucose | 0.67497349 |
| 172 | MP0005390_skeleton_phenotype | 0.67392683 |
| 173 | MP0002069_abnormal_eating/drinking_beha | 0.65754829 |
| 174 | MP0002332_abnormal_exercise_endurance | 0.65440970 |
| 175 | MP0005165_increased_susceptibility_to | 0.64486538 |
| 176 | MP0003705_abnormal_hypodermis_morpholog | 0.61335563 |
| 177 | MP0002090_abnormal_vision | 0.61000133 |
| 178 | MP0005195_abnormal_posterior_eye | 0.60131246 |
| 179 | MP0001664_abnormal_digestion | 0.59877992 |
| 180 | MP0001177_atelectasis | 0.59060363 |
| 181 | MP0000249_abnormal_blood_vessel | 0.57888357 |
| 182 | MP0002254_reproductive_system_inflammat | 0.57646931 |
| 183 | MP0009765_abnormal_xenobiotic_induced | 0.55223318 |
| 184 | MP0003045_fibrosis | 0.55109911 |
| 185 | MP0005647_abnormal_sex_gland | 0.54068604 |
| 186 | MP0001849_ear_inflammation | 0.53995405 |
| 187 | MP0002933_joint_inflammation | 0.53101288 |
| 188 | MP0002877_abnormal_melanocyte_morpholog | 0.50168689 |
| 189 | MP0005666_abnormal_adipose_tissue | 0.50132290 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.19311390 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.99792211 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.99792211 |
| 4 | Abnormality of glycolipid metabolism (HP:0010969) | 5.99792211 |
| 5 | Increased cerebral lipofuscin (HP:0011813) | 5.06326470 |
| 6 | Recurrent abscess formation (HP:0002722) | 4.90441093 |
| 7 | Abnormality of macrophages (HP:0004311) | 4.82829447 |
| 8 | Recurrent bacterial skin infections (HP:0005406) | 4.75029746 |
| 9 | Systemic lupus erythematosus (HP:0002725) | 4.73579807 |
| 10 | Eczematoid dermatitis (HP:0000976) | 4.53814112 |
| 11 | Acute necrotizing encephalopathy (HP:0006965) | 4.45916298 |
| 12 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.32289623 |
| 13 | Vacuolated lymphocytes (HP:0001922) | 4.11459535 |
| 14 | Dysostosis multiplex (HP:0000943) | 4.06455380 |
| 15 | Atonic seizures (HP:0010819) | 3.88525921 |
| 16 | Progressive macrocephaly (HP:0004481) | 3.88193150 |
| 17 | Loss of speech (HP:0002371) | 3.86326740 |
| 18 | Mitochondrial inheritance (HP:0001427) | 3.84107391 |
| 19 | Focal seizures (HP:0007359) | 3.82781426 |
| 20 | Myokymia (HP:0002411) | 3.78021860 |
| 21 | Mediastinal lymphadenopathy (HP:0100721) | 3.75710558 |
| 22 | Disinhibition (HP:0000734) | 3.75266964 |
| 23 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.73670138 |
| 24 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.64042353 |
| 25 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.61496567 |
| 26 | Parakeratosis (HP:0001036) | 3.60256323 |
| 27 | Febrile seizures (HP:0002373) | 3.55691753 |
| 28 | Glomerulonephritis (HP:0000099) | 3.51540514 |
| 29 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.51252339 |
| 30 | Renal Fanconi syndrome (HP:0001994) | 3.43896598 |
| 31 | Myositis (HP:0100614) | 3.38980120 |
| 32 | Acute encephalopathy (HP:0006846) | 3.31494116 |
| 33 | Epileptic encephalopathy (HP:0200134) | 3.31022675 |
| 34 | Increased hepatocellular lipid droplets (HP:0006565) | 3.29794375 |
| 35 | Stomatitis (HP:0010280) | 3.21087201 |
| 36 | Recurrent fungal infections (HP:0002841) | 3.20568000 |
| 37 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.19311804 |
| 38 | Dialeptic seizures (HP:0011146) | 3.19232665 |
| 39 | Recurrent skin infections (HP:0001581) | 3.14495974 |
| 40 | Orchitis (HP:0100796) | 3.14473052 |
| 41 | Neuronal loss in central nervous system (HP:0002529) | 3.12132367 |
| 42 | Obstructive lung disease (HP:0006536) | 3.11750596 |
| 43 | Chronic obstructive pulmonary disease (HP:0006510) | 3.11750596 |
| 44 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.10131079 |
| 45 | Absence seizures (HP:0002121) | 3.10041738 |
| 46 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.08924486 |
| 47 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.08924486 |
| 48 | Increased CSF lactate (HP:0002490) | 2.95834738 |
| 49 | Recurrent cutaneous fungal infections (HP:0011370) | 2.94902743 |
| 50 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.94902743 |
| 51 | Autoimmune thrombocytopenia (HP:0001973) | 2.91225289 |
| 52 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.89331160 |
| 53 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.89331160 |
| 54 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.89331160 |
| 55 | Visual hallucinations (HP:0002367) | 2.89209845 |
| 56 | Optic disc pallor (HP:0000543) | 2.88814619 |
| 57 | Amyloidosis (HP:0011034) | 2.87584318 |
| 58 | Optic neuritis (HP:0100653) | 2.86990394 |
| 59 | Retrobulbar optic neuritis (HP:0100654) | 2.86990394 |
| 60 | Axonal loss (HP:0003447) | 2.85563732 |
| 61 | Generalized tonic-clonic seizures (HP:0002069) | 2.85081379 |
| 62 | Progressive cerebellar ataxia (HP:0002073) | 2.82872292 |
| 63 | Upper motor neuron abnormality (HP:0002127) | 2.81712744 |
| 64 | Meningitis (HP:0001287) | 2.81619215 |
| 65 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.78671677 |
| 66 | Hepatocellular necrosis (HP:0001404) | 2.75714268 |
| 67 | Gingivitis (HP:0000230) | 2.75660620 |
| 68 | Recurrent viral infections (HP:0004429) | 2.74461719 |
| 69 | Hyperventilation (HP:0002883) | 2.74327531 |
| 70 | Apathy (HP:0000741) | 2.74196413 |
| 71 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.72418037 |
| 72 | Mucopolysacchariduria (HP:0008155) | 2.72418037 |
| 73 | Diminished motivation (HP:0000745) | 2.66327195 |
| 74 | Progressive inability to walk (HP:0002505) | 2.65730332 |
| 75 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.63936289 |
| 76 | Peripheral hypomyelination (HP:0007182) | 2.63911509 |
| 77 | Spontaneous hematomas (HP:0007420) | 2.61639896 |
| 78 | Abnormality of the corticospinal tract (HP:0002492) | 2.60566520 |
| 79 | Progressive external ophthalmoplegia (HP:0000590) | 2.59115386 |
| 80 | Neurofibrillary tangles (HP:0002185) | 2.58834934 |
| 81 | Complement deficiency (HP:0004431) | 2.57654731 |
| 82 | Cellulitis (HP:0100658) | 2.56739833 |
| 83 | Leukodystrophy (HP:0002415) | 2.55920783 |
| 84 | Lipid accumulation in hepatocytes (HP:0006561) | 2.55293474 |
| 85 | Purpura (HP:0000979) | 2.55248333 |
| 86 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.51843668 |
| 87 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.51843668 |
| 88 | Increased serum ferritin (HP:0003281) | 2.49008532 |
| 89 | Gait imbalance (HP:0002141) | 2.48135017 |
| 90 | Sensory axonal neuropathy (HP:0003390) | 2.46816759 |
| 91 | Medial flaring of the eyebrow (HP:0010747) | 2.46719362 |
| 92 | Personality changes (HP:0000751) | 2.45881935 |
| 93 | Abnormal ciliary motility (HP:0012262) | 2.45539110 |
| 94 | Colitis (HP:0002583) | 2.44709782 |
| 95 | Abnormality of renal resorption (HP:0011038) | 2.44309137 |
| 96 | Agnosia (HP:0010524) | 2.43906498 |
| 97 | Broad-based gait (HP:0002136) | 2.43827227 |
| 98 | Polyphagia (HP:0002591) | 2.43586462 |
| 99 | Abnormal hair whorl (HP:0010721) | 2.41358353 |
| 100 | 3-Methylglutaconic aciduria (HP:0003535) | 2.33224867 |
| 101 | Limb dystonia (HP:0002451) | 2.32978705 |
| 102 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.30992531 |
| 103 | Petechiae (HP:0000967) | 2.29923809 |
| 104 | Congenital primary aphakia (HP:0007707) | 2.29026683 |
| 105 | Absent/shortened dynein arms (HP:0200106) | 2.28391275 |
| 106 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.28391275 |
| 107 | Hemoptysis (HP:0002105) | 2.26314207 |
| 108 | Vasculitis (HP:0002633) | 2.25759173 |
| 109 | Exercise intolerance (HP:0003546) | 2.25733621 |
| 110 | Abnormality of glycolysis (HP:0004366) | 2.24555895 |
| 111 | Increased serum pyruvate (HP:0003542) | 2.24555895 |
| 112 | Increased IgE level (HP:0003212) | 2.23268972 |
| 113 | Urticaria (HP:0001025) | 2.23102421 |
| 114 | Abnormality of complement system (HP:0005339) | 2.22562313 |
| 115 | Dysmetria (HP:0001310) | 2.20692252 |
| 116 | Thoracic kyphosis (HP:0002942) | 2.20182233 |
| 117 | Vaginal atresia (HP:0000148) | 2.19227159 |
| 118 | Nuclear cataract (HP:0100018) | 2.18245108 |
| 119 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.17164903 |
| 120 | Pulmonary infiltrates (HP:0002113) | 2.16926818 |
| 121 | Inappropriate behavior (HP:0000719) | 2.16595750 |
| 122 | Fetal akinesia sequence (HP:0001989) | 2.15154312 |
| 123 | Genital tract atresia (HP:0001827) | 2.15039776 |
| 124 | Dementia (HP:0000726) | 2.14320031 |
| 125 | Inflammation of the large intestine (HP:0002037) | 2.13247298 |
| 126 | Exertional dyspnea (HP:0002875) | 2.12705586 |
| 127 | Nephrogenic diabetes insipidus (HP:0009806) | 2.12342302 |
| 128 | Gaze-evoked nystagmus (HP:0000640) | 2.12298307 |
| 129 | Abnormality of iron homeostasis (HP:0011031) | 2.12224969 |
| 130 | Gastrointestinal inflammation (HP:0004386) | 2.11797922 |
| 131 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.09703824 |
| 132 | Inability to walk (HP:0002540) | 2.08585936 |
| 133 | Global brain atrophy (HP:0002283) | 2.07948811 |
| 134 | Truncal ataxia (HP:0002078) | 2.05881660 |
| 135 | Osteomyelitis (HP:0002754) | 2.05134467 |
| 136 | Encephalitis (HP:0002383) | 2.04190071 |
| 137 | Abnormal pupillary function (HP:0007686) | 2.03592344 |
| 138 | Progressive neurologic deterioration (HP:0002344) | 2.03465118 |
| 139 | Respiratory failure (HP:0002878) | 2.03197068 |
| 140 | Supranuclear gaze palsy (HP:0000605) | 2.02960339 |
| 141 | Anxiety (HP:0000739) | 2.02026924 |
| 142 | Delusions (HP:0000746) | 2.00864677 |
| 143 | Increased intramyocellular lipid droplets (HP:0012240) | 2.00793511 |
| 144 | Cerebral hypomyelination (HP:0006808) | 1.99831010 |
| 145 | Keratoconjunctivitis sicca (HP:0001097) | 1.98490511 |
| 146 | Panhypogammaglobulinemia (HP:0003139) | 1.98104688 |
| 147 | Cerebral edema (HP:0002181) | 1.97614186 |
| 148 | Slow saccadic eye movements (HP:0000514) | 1.96235884 |
| 149 | Esotropia (HP:0000565) | 1.96175481 |
| 150 | Pustule (HP:0200039) | 1.96167727 |
| 151 | X-linked dominant inheritance (HP:0001423) | 1.96078348 |
| 152 | Hematochezia (HP:0002573) | 1.96031185 |
| 153 | Abnormal eating behavior (HP:0100738) | 1.95965835 |
| 154 | T lymphocytopenia (HP:0005403) | 1.95894926 |
| 155 | Memory impairment (HP:0002354) | 1.95555319 |
| 156 | Mutism (HP:0002300) | 1.95049220 |
| 157 | Spastic gait (HP:0002064) | 1.94866453 |
| 158 | Pathologic fracture (HP:0002756) | 1.94812228 |
| 159 | Epistaxis (HP:0000421) | 1.94309449 |
| 160 | Hemiparesis (HP:0001269) | 1.93346671 |
| 161 | Amblyopia (HP:0000646) | 1.93221208 |
| 162 | Scanning speech (HP:0002168) | 1.91185451 |
| 163 | Basal ganglia calcification (HP:0002135) | 1.91107126 |
| 164 | Polygenic inheritance (HP:0010982) | 1.90837259 |
| 165 | Myocardial infarction (HP:0001658) | 1.89520427 |
| 166 | Cerebral inclusion bodies (HP:0100314) | 1.88874817 |
| 167 | Leukocytosis (HP:0001974) | 1.85670132 |
| 168 | Gastrointestinal infarctions (HP:0005244) | 1.83968199 |
| 169 | Hepatic necrosis (HP:0002605) | 1.82752759 |
| 170 | Spondylolisthesis (HP:0003302) | 1.81822912 |
| 171 | Abnormality of the periventricular white matter (HP:0002518) | 1.81780273 |
| 172 | Peripheral demyelination (HP:0011096) | 1.80668223 |
| 173 | Restrictive lung disease (HP:0002091) | 1.79801295 |
| 174 | Gastrointestinal stroma tumor (HP:0100723) | 1.79615880 |
| 175 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.78501236 |
| 176 | Excessive salivation (HP:0003781) | 1.77732940 |
| 177 | Drooling (HP:0002307) | 1.77732940 |
| 178 | Diplopia (HP:0000651) | 1.77008992 |
| 179 | Abnormality of binocular vision (HP:0011514) | 1.77008992 |
| 180 | Interstitial pulmonary disease (HP:0006530) | 1.76786963 |
| 181 | Bone pain (HP:0002653) | 1.76466166 |
| 182 | Lactic acidosis (HP:0003128) | 1.75756262 |
| 183 | Generalized myoclonic seizures (HP:0002123) | 1.73010861 |
| 184 | Increased serum lactate (HP:0002151) | 1.72410157 |
| 185 | Hepatosplenomegaly (HP:0001433) | 1.71592596 |
| 186 | Pancreatic fibrosis (HP:0100732) | 1.71468996 |
| 187 | Abnormality of midbrain morphology (HP:0002418) | 1.71162297 |
| 188 | Molar tooth sign on MRI (HP:0002419) | 1.71162297 |
| 189 | Cerebral hemorrhage (HP:0001342) | 1.70760985 |
| 190 | Akinesia (HP:0002304) | 1.68370913 |
| 191 | Dysdiadochokinesis (HP:0002075) | 1.67583558 |
| 192 | Abnormality of the axillary hair (HP:0100134) | 1.67100969 |
| 193 | Abnormality of secondary sexual hair (HP:0009888) | 1.67100969 |
| 194 | Diminished movement (HP:0002374) | 1.66347580 |
| 195 | Cupped ear (HP:0000378) | 1.66281591 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PNCK | 3.35425512 |
| 2 | NTRK3 | 2.96633622 |
| 3 | CASK | 2.87306296 |
| 4 | RIPK4 | 2.81762793 |
| 5 | TNIK | 2.69929266 |
| 6 | MARK1 | 2.68881174 |
| 7 | ERN1 | 2.57719201 |
| 8 | MAP4K1 | 2.55188295 |
| 9 | MAP3K14 | 2.46461488 |
| 10 | MAP2K3 | 2.36218797 |
| 11 | TYK2 | 2.27407555 |
| 12 | NME2 | 2.25745633 |
| 13 | FES | 2.21809427 |
| 14 | MAP2K7 | 2.21221264 |
| 15 | CSF1R | 2.14762976 |
| 16 | GRK7 | 2.13460049 |
| 17 | MAP3K12 | 2.06574788 |
| 18 | MAP3K4 | 2.06257213 |
| 19 | MAP3K11 | 2.05664013 |
| 20 | EPHA4 | 2.04005885 |
| 21 | TGFBR2 | 1.92713483 |
| 22 | KIT | 1.91859764 |
| 23 | TAOK1 | 1.88095976 |
| 24 | STK16 | 1.85224276 |
| 25 | TBK1 | 1.84179664 |
| 26 | GRK5 | 1.81669177 |
| 27 | IRAK4 | 1.80905946 |
| 28 | ADRBK2 | 1.79728010 |
| 29 | MAP3K9 | 1.74972529 |
| 30 | IRAK3 | 1.73576843 |
| 31 | STK39 | 1.73134967 |
| 32 | BMPR2 | 1.69855454 |
| 33 | OXSR1 | 1.69663585 |
| 34 | CSK | 1.69072100 |
| 35 | TAOK2 | 1.68789653 |
| 36 | NME1 | 1.66629058 |
| 37 | ZAP70 | 1.58085773 |
| 38 | PINK1 | 1.57909447 |
| 39 | RIPK1 | 1.57824011 |
| 40 | ARAF | 1.56480915 |
| 41 | MAP3K3 | 1.53468970 |
| 42 | IRAK2 | 1.52297135 |
| 43 | MST4 | 1.52250706 |
| 44 | CDK19 | 1.51487964 |
| 45 | SYK | 1.46066370 |
| 46 | FGR | 1.42250941 |
| 47 | CAMK1D | 1.38485843 |
| 48 | MATK | 1.37905970 |
| 49 | PKN1 | 1.34152349 |
| 50 | MAPK13 | 1.34078168 |
| 51 | JAK3 | 1.32352421 |
| 52 | TRIB3 | 1.32274079 |
| 53 | PLK2 | 1.31341181 |
| 54 | NTRK1 | 1.25458696 |
| 55 | MAP3K1 | 1.23782948 |
| 56 | MINK1 | 1.20250570 |
| 57 | IKBKB | 1.19200136 |
| 58 | MAP2K4 | 1.18584061 |
| 59 | IKBKE | 1.16800157 |
| 60 | CAMK2B | 1.16577745 |
| 61 | LYN | 1.10934830 |
| 62 | CDC42BPA | 1.10699439 |
| 63 | JAK2 | 1.10225782 |
| 64 | NEK6 | 1.10207950 |
| 65 | JAK1 | 1.07301172 |
| 66 | BMPR1B | 1.06729573 |
| 67 | PLK4 | 1.04676711 |
| 68 | BTK | 1.04442502 |
| 69 | CAMK2A | 1.03522429 |
| 70 | HCK | 1.01489641 |
| 71 | MARK2 | 1.01448319 |
| 72 | SIK2 | 1.00075730 |
| 73 | NTRK2 | 0.98375295 |
| 74 | ZAK | 0.96923851 |
| 75 | TESK2 | 0.96316082 |
| 76 | PIM2 | 0.94751163 |
| 77 | PDPK1 | 0.94300216 |
| 78 | BCR | 0.93572831 |
| 79 | CDK5 | 0.92541288 |
| 80 | MOS | 0.91765203 |
| 81 | PDK1 | 0.90257844 |
| 82 | ICK | 0.89872432 |
| 83 | SMG1 | 0.89038700 |
| 84 | MAPK12 | 0.87978594 |
| 85 | CAMKK1 | 0.87909605 |
| 86 | MAP3K13 | 0.87584495 |
| 87 | MAPK15 | 0.87427927 |
| 88 | DDR2 | 0.85024925 |
| 89 | LCK | 0.83450405 |
| 90 | PBK | 0.83285118 |
| 91 | PRKCG | 0.82722546 |
| 92 | CDK6 | 0.82219067 |
| 93 | UHMK1 | 0.82148586 |
| 94 | MAPKAPK5 | 0.81912522 |
| 95 | CAMK2D | 0.79257732 |
| 96 | PRKCE | 0.78587891 |
| 97 | EPHB1 | 0.78291708 |
| 98 | IRAK1 | 0.78242162 |
| 99 | STK10 | 0.78085262 |
| 100 | CAMK1G | 0.77708316 |
| 101 | PRKD2 | 0.76201153 |
| 102 | AKT3 | 0.75797964 |
| 103 | CSNK1G3 | 0.75723634 |
| 104 | EIF2AK3 | 0.75561151 |
| 105 | CSNK1G2 | 0.73139940 |
| 106 | KSR2 | 0.72329013 |
| 107 | MUSK | 0.69104338 |
| 108 | GRK6 | 0.68958531 |
| 109 | VRK1 | 0.68390833 |
| 110 | CAMKK2 | 0.68022814 |
| 111 | MARK3 | 0.66590117 |
| 112 | TXK | 0.66413005 |
| 113 | BUB1 | 0.66108046 |
| 114 | CDK12 | 0.65473375 |
| 115 | BRAF | 0.65439577 |
| 116 | CLK1 | 0.64707664 |
| 117 | GRK1 | 0.63890099 |
| 118 | PAK6 | 0.62936181 |
| 119 | CAMK2G | 0.62775212 |
| 120 | MAPK7 | 0.62030078 |
| 121 | CAMK1 | 0.58496189 |
| 122 | RPS6KC1 | 0.56943372 |
| 123 | RPS6KL1 | 0.56943372 |
| 124 | WNK4 | 0.56844378 |
| 125 | MAP2K6 | 0.56744659 |
| 126 | EEF2K | 0.56335640 |
| 127 | TLK1 | 0.56331025 |
| 128 | WNK1 | 0.55442756 |
| 129 | DYRK1A | 0.55150969 |
| 130 | SIK3 | 0.53981897 |
| 131 | MAP3K6 | 0.53351409 |
| 132 | SRPK1 | 0.53307135 |
| 133 | ROCK2 | 0.52988907 |
| 134 | ABL2 | 0.51885236 |
| 135 | DAPK2 | 0.51795538 |
| 136 | SGK223 | 0.51195943 |
| 137 | SGK494 | 0.51195943 |
| 138 | SIK1 | 0.50767375 |
| 139 | PLK3 | 0.50245773 |
| 140 | PRPF4B | 0.49916649 |
| 141 | MAPK4 | 0.49488541 |
| 142 | CSNK1A1L | 0.49069348 |
| 143 | RPS6KA2 | 0.48330208 |
| 144 | ADRBK1 | 0.48239430 |
| 145 | TNK2 | 0.46987450 |
| 146 | CDK4 | 0.46785858 |
| 147 | PRKACA | 0.46740082 |
| 148 | MAP3K5 | 0.46648962 |
| 149 | ACVR1B | 0.44289067 |
| 150 | ITK | 0.42920289 |
| 151 | CDK14 | 0.42864167 |
| 152 | FYN | 0.42258244 |
| 153 | CHUK | 0.42128799 |
| 154 | MAP3K8 | 0.41728896 |
| 155 | RPS6KA6 | 0.41322456 |
| 156 | YES1 | 0.41305024 |
| 157 | BLK | 0.40678653 |
| 158 | CDK18 | 0.40528255 |
| 159 | HIPK2 | 0.40439864 |
| 160 | INSRR | 0.40386565 |
| 161 | ERBB4 | 0.40307473 |
| 162 | CDK15 | 0.40227703 |
| 163 | PTK2B | 0.40159754 |
| 164 | PRKG1 | 0.39510784 |
| 165 | PIM1 | 0.39166154 |
| 166 | CDK11A | 0.38834194 |
| 167 | TAOK3 | 0.38302735 |
| 168 | DYRK2 | 0.37933218 |
| 169 | SGK1 | 0.37357088 |
| 170 | ALK | 0.36868489 |
| 171 | EIF2AK2 | 0.36036725 |
| 172 | CSNK1G1 | 0.35989064 |
| 173 | TEC | 0.34930606 |
| 174 | TESK1 | 0.32789298 |
| 175 | FLT3 | 0.31970007 |
| 176 | PRKD3 | 0.31191560 |
| 177 | CAMK4 | 0.28843189 |
| 178 | SGK3 | 0.28244287 |
| 179 | DAPK1 | 0.26131141 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.54690191 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.67353062 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 3.61836602 |
| 4 | Parkinsons disease_Homo sapiens_hsa05012 | 3.53530466 |
| 5 | Alzheimers disease_Homo sapiens_hsa05010 | 3.02762537 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.94309558 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 2.80684697 |
| 8 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.65480972 |
| 9 | Huntingtons disease_Homo sapiens_hsa05016 | 2.61243929 |
| 10 | Lysosome_Homo sapiens_hsa04142 | 2.56421721 |
| 11 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.50023217 |
| 12 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.44525840 |
| 13 | GABAergic synapse_Homo sapiens_hsa04727 | 2.42846730 |
| 14 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.34510346 |
| 15 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.32206877 |
| 16 | Tuberculosis_Homo sapiens_hsa05152 | 2.28614384 |
| 17 | Morphine addiction_Homo sapiens_hsa05032 | 2.25623651 |
| 18 | Serotonergic synapse_Homo sapiens_hsa04726 | 2.25536299 |
| 19 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.12274741 |
| 20 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.08984350 |
| 21 | Asthma_Homo sapiens_hsa05310 | 2.04753961 |
| 22 | Allograft rejection_Homo sapiens_hsa05330 | 2.02308931 |
| 23 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.97673368 |
| 24 | RNA polymerase_Homo sapiens_hsa03020 | 1.96087270 |
| 25 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.96027601 |
| 26 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.91036212 |
| 27 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.87636522 |
| 28 | Taste transduction_Homo sapiens_hsa04742 | 1.86244631 |
| 29 | Proteasome_Homo sapiens_hsa03050 | 1.83264589 |
| 30 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.81448937 |
| 31 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.78557965 |
| 32 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.77701145 |
| 33 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.75124044 |
| 34 | Pertussis_Homo sapiens_hsa05133 | 1.74240898 |
| 35 | Legionellosis_Homo sapiens_hsa05134 | 1.71054644 |
| 36 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.68337052 |
| 37 | Circadian entrainment_Homo sapiens_hsa04713 | 1.68216509 |
| 38 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.66440754 |
| 39 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.65783405 |
| 40 | Malaria_Homo sapiens_hsa05144 | 1.63271332 |
| 41 | Olfactory transduction_Homo sapiens_hsa04740 | 1.60621384 |
| 42 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.57190864 |
| 43 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.55697609 |
| 44 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.55282947 |
| 45 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.53343984 |
| 46 | Ribosome_Homo sapiens_hsa03010 | 1.52122971 |
| 47 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.52072995 |
| 48 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.51399394 |
| 49 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.48982520 |
| 50 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.47469372 |
| 51 | Influenza A_Homo sapiens_hsa05164 | 1.45291847 |
| 52 | Long-term depression_Homo sapiens_hsa04730 | 1.41145478 |
| 53 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.39488280 |
| 54 | Salivary secretion_Homo sapiens_hsa04970 | 1.39164080 |
| 55 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.38515576 |
| 56 | Long-term potentiation_Homo sapiens_hsa04720 | 1.35707773 |
| 57 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.35044300 |
| 58 | Salmonella infection_Homo sapiens_hsa05132 | 1.33612973 |
| 59 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.31825599 |
| 60 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.30090019 |
| 61 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.29419935 |
| 62 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.28470615 |
| 63 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.26316596 |
| 64 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.25985115 |
| 65 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.23708740 |
| 66 | Phototransduction_Homo sapiens_hsa04744 | 1.22890908 |
| 67 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.22133302 |
| 68 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.21332315 |
| 69 | Protein export_Homo sapiens_hsa03060 | 1.19001576 |
| 70 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.16083909 |
| 71 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.13169298 |
| 72 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.08715186 |
| 73 | Viral myocarditis_Homo sapiens_hsa05416 | 1.06834515 |
| 74 | Measles_Homo sapiens_hsa05162 | 1.05899797 |
| 75 | Cocaine addiction_Homo sapiens_hsa05030 | 1.04400379 |
| 76 | Insulin secretion_Homo sapiens_hsa04911 | 1.03592471 |
| 77 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.03211274 |
| 78 | Renin secretion_Homo sapiens_hsa04924 | 0.99208869 |
| 79 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.99060822 |
| 80 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.97058313 |
| 81 | Axon guidance_Homo sapiens_hsa04360 | 0.96707325 |
| 82 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.95569209 |
| 83 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.95082109 |
| 84 | Hepatitis C_Homo sapiens_hsa05160 | 0.94112819 |
| 85 | Hepatitis B_Homo sapiens_hsa05161 | 0.92643016 |
| 86 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.91333314 |
| 87 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.91183382 |
| 88 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.89297549 |
| 89 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.89289227 |
| 90 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.84915938 |
| 91 | Shigellosis_Homo sapiens_hsa05131 | 0.84095147 |
| 92 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.83999096 |
| 93 | Apoptosis_Homo sapiens_hsa04210 | 0.82146147 |
| 94 | Platelet activation_Homo sapiens_hsa04611 | 0.79561729 |
| 95 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.79112439 |
| 96 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.77377683 |
| 97 | Amoebiasis_Homo sapiens_hsa05146 | 0.74832479 |
| 98 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.73992461 |
| 99 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.72265250 |
| 100 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.72240164 |
| 101 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.71346182 |
| 102 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.70797015 |
| 103 | * Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.69271034 |
| 104 | Phagosome_Homo sapiens_hsa04145 | 0.68962229 |
| 105 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.68888600 |
| 106 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.68294410 |
| 107 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.67753658 |
| 108 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.66751091 |
| 109 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.66492696 |
| 110 | Bladder cancer_Homo sapiens_hsa05219 | 0.66041348 |
| 111 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.65556438 |
| 112 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.65461276 |
| 113 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.64016876 |
| 114 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.62802785 |
| 115 | Endocytosis_Homo sapiens_hsa04144 | 0.62474723 |
| 116 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.61274460 |
| 117 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.59100128 |
| 118 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.59054852 |
| 119 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.57936601 |
| 120 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.57894289 |
| 121 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.57471245 |
| 122 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.57372395 |
| 123 | Gap junction_Homo sapiens_hsa04540 | 0.55946010 |
| 124 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.54295842 |
| 125 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.51683679 |
| 126 | Purine metabolism_Homo sapiens_hsa00230 | 0.51452126 |
| 127 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.51451606 |
| 128 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.50511289 |
| 129 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.50328624 |
| 130 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.49905295 |
| 131 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.47856591 |
| 132 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.46372905 |
| 133 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.45995663 |
| 134 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.45777576 |
| 135 | HTLV-I infection_Homo sapiens_hsa05166 | 0.45589542 |
| 136 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.44956129 |
| 137 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.44840535 |
| 138 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.44432333 |
| 139 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.44155758 |
| 140 | Metabolic pathways_Homo sapiens_hsa01100 | 0.43944364 |
| 141 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.43424870 |
| 142 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.41622684 |
| 143 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.40589450 |
| 144 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.40278588 |
| 145 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.39559605 |
| 146 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.37962716 |
| 147 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.37350340 |
| 148 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.37283616 |
| 149 | Alcoholism_Homo sapiens_hsa05034 | 0.36973772 |
| 150 | Prion diseases_Homo sapiens_hsa05020 | 0.35246231 |
| 151 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.34193963 |
| 152 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.33933162 |
| 153 | Galactose metabolism_Homo sapiens_hsa00052 | 0.33543114 |
| 154 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.32936651 |
| 155 | Glioma_Homo sapiens_hsa05214 | 0.32702969 |
| 156 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.32702856 |
| 157 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.32225745 |
| 158 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.30682669 |
| 159 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.30019059 |
| 160 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.28989493 |
| 161 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.28426004 |
| 162 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.26491501 |
| 163 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.25884206 |
| 164 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.25196860 |
| 165 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.24828077 |
| 166 | Histidine metabolism_Homo sapiens_hsa00340 | 0.23024750 |
| 167 | Melanogenesis_Homo sapiens_hsa04916 | 0.22916614 |
| 168 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.22831428 |
| 169 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.22532735 |
| 170 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.22498738 |
| 171 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.20242015 |
| 172 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.18745808 |

